C. Ryan Miller

Thomas Jefferson University

Papers

1

Total Citations

3

H-Index

1

About

C. Ryan Miller is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). His work critically examines the intersection of surgical timing and adjuvant radiation therapy (RT) to optimize multimodal treatment outcomes. In his most cited study, a multi-institutional cohort analysis published in 2024, Miller investigated the association between the time from surgery to the start of radiation therapy (TSRT) and patient prognosis. His findings challenge conventional wisdom by providing nuanced data on whether delays beyond the standard six-week window compromise survival in this specific patient population. This work has already garnered 3 citations, reflecting its immediate relevance to clinical practice guidelines. Miller’s contributions help refine the delicate balance between allowing adequate surgical recovery and ensuring timely oncologic treatment, directly impacting decision-making for multidisciplinary care teams. By leveraging large, collaborative datasets, he provides evidence-based insights that shape how HPV+ head and neck cancer patients are managed, making his research essential reading for surgeons, radiation oncologists, and trainees navigating complex treatment sequencing.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort Experience
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Thomas Jefferson University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago